Abstract:Background Human babesiosis is an infectious disease that is epidemic in various regions all over the world. The predominant causative pathogen of this disease is the intra-erythrocytic parasite Babesia microti . The thioredoxin system is one of the major weapons that is used in the resistance to the reactive oxygen species (ROS) and reactive nitrogen species (RNS) produced by host immune system. In other intra-erythrocytic apicomplexans like the malaria parasite Plasmodium falciparum , anti-oxidative proteins are promising targets for the development of anti-parasitic drugs. However, to date, the sequences and biological properties of thioredoxins and thioredoxin-like molecules of B. microti remain unknown. Understanding the molecular characterization and function of B. microti thioredoxins may help to develop anti- Babesia drugs and controlling babesiosis. Methods The full-length B. microti thioredoxin 2 ( BmTrx2 ) gene was obtained using a rapid amplification of cDNA ends (RACE) method, and the deduced BmTrx2 amino acid sequence was analyzed using regular bioinformatics tools. Recombinant BmTrx2 protein was expressed in vitro and purified using His-tag protein affinity chromatography resins. Reverse transcription PCR, quantitative real-time PCR and Western blot were employed to detect the expression and native proteins of BmTrx2. Indirect immunofluorescence assay was used to localize BmTrx2 in B. microti . Bovine insulin reduction assays were used to determine the enzyme activity of the purified recombinant BmTrx2 protein. Results The full-length BmTrx2 was 564 bp with a 408 bp open reading frame encoding a protein of 135 amino acids. The predicted molecular weight of the protein was 15.5 kDa. A conserved thioredoxin-like family domain was found in BmTrx2 . The expression of BmTrx2 was upregulated on both the third and eighth day post-infection in mice, whereas expression was downregulated during the beginning and later stages. The results of Western blot analysis showed the native BmTrx2 in parasite lysates could be detected by mouse anti-BmTrx2 serum and that the recombinant BmTrx2 protein could be recognized by serum of B. microti -infected mice. Immunofluorescence microscopy showed that BmTrx2 localized in the cell cytoplasm of B. microti merozoites in B. microti- infected red blood cells. The results of bovine insulin reduction assay indicated the purified recombinant BmTrx2 protein possesses antioxidant enzyme activity. Dihydroartemisinin and quinine, known anti-malaria drugs, and clindamycin, a known anti-babesiosis drug, induced significantly higher upregulation of BmTrx2 mRNA. Conclusions Our results indicate that BmTrx2 is a functional enzyme with antioxidant activity and may be involved in the response of B. microti to anti-parasite drugs.

Expression of Truncated Babesia Microti Apical Membrane Protein 1 and Rhoptry Neck Protein 2 and Evaluation of Their Protective Efficacy.

Evaluation of the Protective Effect of a Prime-Boost Strategy with Plasmid DNA Followed by Recombinant Adenovirus Expressing BmAMA1 As Vaccines Against Babesia Microti Infection in Hamster

Molecular Characterization and Immunological Evaluation of Truncated Babesia microti Rhoptry Neck Protein 2 as a Vaccine Candidate

A Long-Lasting Protective Immunity Against Chronic Toxoplasmosis in Mice Induced by Recombinant Rhoptry Proteins Encapsulated in Poly (Lactide-Co-glycolide) Microparticles.

A Conserved Protein of Babesia Microti Elicits Partial Protection Against Babesia and Plasmodium Infection.

Macrophages Are Critical for Cross-Protective Immunity Conferred by Babesia Microti Against Babesia Rodhaini Infection in Mice

Babesia microti Protein BmSP44 Is a Novel Protective Antigen in a Mouse Model of Babesiosis

Identification and Characterization of a Novel Secreted Antigen 1 of Babesia Microti and Evaluation of Its Potential Use in Enzyme-Linked Immunosorbent Assay and Immunochromatographic Test

Babesia Microti Protein Bm SP44 is a Novel Protective Antigen in a Mouse Model of Babesiosis

[Expression and Immunogenicity Evaluation of Ectodomain and Subdomains of Plasmodium Berghei Apical Membrane Antigen 1].

Expression and evaluation of diagnostic candidate antigens from Babesia microti

Evaluation of a Major Surface Antigen of Babesia Microti Merozoites As a Vaccine Candidate Against Babesia Infection

Molecular characterization of Babesia microti seroreactive antigen 5-1-1 and development of rapid detection methods for anti-B. microti antibodies in serum.

[Immunoprotective Effects of Helicobacter Pylori UreB and HpaA Bivalence Recombinant Vaccine with Inner Adjuvant on Experimental Infection in Mice].

Molecular characterization of Babesia microti thioredoxin (BmTrx2) and its expression patterns induced by antiprotozoal drugs

Screening for Biomarkers Reflecting the Progression of Babesia Microti Infection

Surface Antigen 1 is a Crucial Secreted Protein That Mediates Babesia Microti Invasion into Host Cells

Production and Characterization of Monoclonal Antibody Against Mycobacterium Tuberculosis RpfB Domain.

Recombinant Vaccinia Virus Expressing Plasmodium Berghei Apical Membrane Antigen 1 or Microneme Protein Enhances Protection Against P. Berghei Infection in Mice

Therapeutic Efficacy of Micrococcus Luteus Rpf Domain and its Mutants against Mycobacterium Tuberculosis in Mice

Recombinant methionine aminopeptidase protein of Babesia microti: immunobiochemical characterization as a vaccine candidate against human babesiosis